Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1Phase 1/2 1

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 11Genitourinary 10Gastrointestinal 6Sarcoma 5Gynecologic 4Thoracic 3Head & Neck 3Other solid neoplasm 1Endocrine 1CNS 1

Conditions

Uterine Cervical Neoplasms 3Endometrial Neoplasms 2

Interventions

Paclitaxel 140pembrolizumab 119Carboplatin 104Bevacizumab 90Cisplatin 67Specimen Handling 62Magnetic Resonance Spectroscopy 51olaparib 50Gemcitabine 39Nivolumab 36Biopsy 36liposomal doxorubicin 32Taxes 31Cyclophosphamide 31Blood Specimen Collection 29niraparib 27lenvatinib 26Letrozole 26Doxorubicin 26Topotecan 25Drug Therapy 25Immunoglobulin G 22fludarabine 21atezolizumab 21Radiotherapy 21Brachytherapy 21Disulfides 20durvalumab 19Surveys and Questionnaires 19dostarlimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Radiation Dose Hypofractionation × Gynecologic × 1 year × Clear all
NCT07605507 2026-05-26

HYPOCx-iRex

Siriraj Hospital

Phase NA Active not recruiting
40 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07595224 2026-05-19

PostOP HYPOCxE

Siriraj Hospital

Phase NA Recruiting
120 enrolled
Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT07276360 2026-03-27

HypoRTCx-UG

Uganda Cancer Institute

Phase 2 Recruiting
278 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04683653 2025-12-29

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

University of Chicago

Phase 1/2 Recruiting
100 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡